Multidrug-resistant tuberculosis in children: evidence from global surveillance

被引:68
作者
Zignol, Matteo [1 ]
Sismanidis, Charalambos [1 ]
Falzon, Dennis [1 ]
Glaziou, Philippe [1 ]
Dara, Masoud [2 ]
Floyd, Katherine [1 ]
机构
[1] WHO, STOP TB Dept, CH-1211 Geneva 27, Switzerland
[2] WHO, Reg Off Europe, TB & MXDR TB Programme, DK-2100 Copenhagen, Denmark
关键词
ANTITUBERCULOSIS DRUG-RESISTANCE; WESTERN CAPE PROVINCE; PULMONARY TUBERCULOSIS; CHILDHOOD TUBERCULOSIS; SOUTH-AFRICA; CONTACT; MANAGEMENT;
D O I
10.1183/09031936.00175812
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Multidrug-resistant tuberculosis (MDR-TB) can affect persons of any age, but it remains unknown whether children are more or less likely than adults to have MDR-TB. Representative drug resistance surveillance data reported to the World Health Organization between 1994 and 2011 were analysed to test the association between MDR-TB and age group (children aged <15 years versus adults aged >= 15 years), using odds ratios derived by logistic regression with robust standard errors. Of 85 countries with data from nationwide surveys or surveillance systems, 35 reported at least one paediatric MDR-TB case. Aggregated data on age and drug susceptibility testing for 323 046 tuberculosis cases notified in these 35 countries were analysed. Odds ratios for MDR-TB in children compared to adults varied widely between countries. In Germany, Namibia, South Africa, the UK and the USA, MDR-TB was positively associated with age <15 years. In the remaining countries no association was established. Despite the limitations intrinsic to the use of surveillance data and to the challenges of diagnosing childhood tuberculosis, our analysis suggests that proportions of MDR-TB in children and adults are similar in many settings. Of particular concern is the association found between age <15 years and MDR-TB in southern African countries with high HIV prevalence.
引用
收藏
页码:701 / 707
页数:7
相关论文
共 30 条
[21]   Evaluation of young children in household contact with adult multidrug-resistant pulmonary tuberculosis cases [J].
Schaaf, HS ;
Vermeulen, HAS ;
Gie, RP ;
Beyers, N ;
Donald, PR .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1999, 18 (06) :494-500
[22]   Culture-Confirmed Multidrug-Resistant Tuberculosis in Children: Clinical Features, Treatment, and Outcome [J].
Seddon, James A. ;
Hesseling, Anneke C. ;
Willemse, Marianne ;
Donald, Peter R. ;
Schaaf, H. Simon .
CLINICAL INFECTIOUS DISEASES, 2012, 54 (02) :157-166
[24]  
Swaminathan S, 2008, INDIAN PEDIATR, V45, P743
[25]  
WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
[26]  
WHO, 2009, WHO PUBL
[27]  
World Health Organization, TB DAT
[28]   Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance [J].
Wright, Abigail ;
Zignol, Matteo ;
Van Deun, Armand ;
Falzon, Dennis ;
Gerdes, Sabine Ruesch ;
Feldman, Knut ;
Hoffner, Sven ;
Drobniewski, Francis ;
Barrera, Lucia ;
van Soolingen, Dick ;
Boulabhal, Fadila ;
Paramasivan, C. N. ;
Kam, Kai Man ;
Mitarai, Satoshi ;
Nunn, Paul ;
Raviglione, Mario .
LANCET, 2009, 373 (9678) :1861-1873
[29]   Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010 [J].
Zignol, Matteo ;
van Gemert, Wayne ;
Falzon, Dennis ;
Sismanidis, Charalambos ;
Glaziou, Philippe ;
Floyd, Katherine ;
Raviglione, Mario .
BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2012, 90 (02) :111-119
[30]   Modernizing Surveillance of Antituberculosis Drug Resistance: From Special Surveys to Routine Testing [J].
Zignol, Matteo ;
van Gemert, Wayne ;
Falzon, Dennis ;
Jaramillo, Ernesto ;
Blanc, Leopold ;
Raviglione, Mario .
CLINICAL INFECTIOUS DISEASES, 2011, 52 (07) :901-906